Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/1999
11/03/1999EP0953637A2 Acetylcholine receptor
11/03/1999EP0953636A2 Cytokine signal regulators
11/03/1999EP0953153A1 Novel method of diagnosing and treating gliomas
11/03/1999EP0953050A1 Novel means for the diagnosis, prevention and treatment of contamination or infections by viruses with mucous tropism
11/03/1999EP0953049A2 Novel human metallothionein
11/03/1999EP0953048A1 Compounds for modulating cell negative regulations and biological applications thereof
11/03/1999EP0953046A1 Human hematopoietic stem and progenitor cell antigen and methods for its use
11/03/1999EP0953043A1 Genes and gene products related to werner's syndrome
11/03/1999EP0953042A1 Methods and reagents for regulating telomere length and telomerase activity
11/03/1999EP0952987A2 Antibodies against epitopes, exposed on surfaces of cancer cells outside desmosomes, of desmosomal cadherines
11/03/1999EP0952985A1 Broad spectrum pyrogenic exotoxins antagonists and vaccines
11/03/1999EP0952834A2 Isopentenyl pyrophosphate isomerase (ipi) and/or prenyl transferase inhibitors
11/03/1999EP0754058B1 Wound healing
11/03/1999EP0693121A4 Monoclonal antibody 88bv59, subclones and method of making
11/03/1999EP0371998B2 Modular assembly of antibody genes, antibodies prepared thereby and use
11/03/1999CN1234118A Material and method relating to diagnosis and treatment of diabetes and obesity
11/03/1999CN1234078A Compositions and method for treating viral infections
11/03/1999CN1234072A Anti-ErbB2 antibodies
11/02/1999US5977338 Polynucleotides which hybridize with naturally occurring sequences encoding human interferon-inducible protein (hifi) and the polynucleotides which identify and encode hifi.
11/02/1999US5977323 Purifying inflammatory cytokine/chemokine by immunoaffinity chromatography; complexing chemokine to anti-gro antibodies bound to matrix, eluting chemokine
11/02/1999US5977322 Human antibody that specifically binds to c-erbb-2 protein product of her2/neu oncogene; for diagnosis of cancer/tumors which over express this gene; for immunotoxins and other antitumor/anticarcinogenic agents; less immunogenic
11/02/1999US5977321 The subunit consists of variable, joining, constant, transmembrane, and cytoplasmic regions.
11/02/1999US5977319 Specific binding members for estradiol; materials and methods
11/02/1999US5977318 The ctla4 receptor as a ligand for the b7 antigen.
11/02/1999US5977316 Antiidiotypic antibody which induces immune response to ganglioside gd2; anticarcinogenic/antitumor agents against melanoma, neuroblastoma, glioma, soft tissue sarcoma, and small cell carcinoma; for decreasing the risk of recurrence
11/02/1999US5977315 Murine anti-idiotype antibody 3H1
11/02/1999US5977314 Catalytic antibodies against cocaine
11/02/1999US5977311 53BP2 complexes
11/02/1999US5977307 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
11/02/1999US5977303 Mammalian cell surface antigens
11/02/1999US5977296 Chiral peptide nucleic acid monomers and oligomers
11/02/1999US5977160 Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
11/02/1999US5977085 Vectors carrying coding sequence for the SpsB protein of Staphylococcus aureus
11/02/1999US5977072 Polypeptide
11/02/1999US5976877 Proteins produced by human lymphocytes DNA sequence encoding these proteins and their pharmaceutical and biological uses
11/02/1999US5976876 Antibodies specific for hLH β core fragment
11/02/1999US5976852 Isolated nucleic acid molecule encoding a receptor protein; for identifying agonists and antagonists; treatment of paralytic disease; antitumor/antimetastasis agents
11/02/1999US5976849 Human E3 ubiquitin protein ligase
11/02/1999US5976845 Composite antibodies of human subgroup IV light chain capable of binding to TAG-72
11/02/1999US5976835 Nucleic acids encoding receptor recognition factor Stat1α and Stat1β, and methods of use thereof
11/02/1999US5976834 cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor
11/02/1999US5976832 DNA encoding novel calcium-binding proteins
11/02/1999US5976821 Monoclonal antibodies specific for human interleukin-5
11/02/1999US5976818 Ca 125 is an antigenic determinant or epitope located on the surface of ovarian tumor cells with essentially no expression in normal adult ovarian tissue. however, ca 125 is expressed on the cell surface of tumor cells in culture and on ovarian
11/02/1999US5976816 Cell tests for alzheimer's disease
11/02/1999US5976815 Screening drugs/ligands of activin receptor-like kinase 7 receptor by transfecting host cell with nucleic acid encoding receptor protein, contacting cell with drug/ligand, evaluating effect on kinase activity
11/02/1999US5976811 Antibody which is prepared by immunizing animal with homopolymer of units of g-x-a where g is a bile acid, salt or ester, x is a bridge group and a is a polymerizable, ethenically unsaturated group
11/02/1999US5976796 The gene product alone can be sufficient to allow detection of living cells under the light microscope.
11/02/1999US5976545 ZPC polypeptides
11/02/1999US5976539 Compositions and methods for use of IL-12 as an adjuvant
11/02/1999US5976535 Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
11/02/1999US5976534 Inhibition of intimal hyperplasia using antibodies to PDGF receptors and heparin
11/02/1999US5976533 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
11/02/1999US5976532 Method of antithrombotic therapy using anti-GPIIb/IIIa antibodies or fragments thereof, including c7E3
11/02/1999US5976531 Composite antibodies of human subgroup IV light chain capable of binding to tag-72
11/02/1999US5976522 Lymphocyte chemoattractant factor and uses thereof
11/02/1999US5976519 Obtained from an egg of a domestic fowl immunized using, as an antigen, whole human hair, e.g., normal human hair or human hair damaged by permanent waving, dyeing or bleaching, or hair particles
11/02/1999US5976492 Radioactive phosphorus labeled proteins for targeted radiotherapy
11/02/1999CA2119443C Human cyclin e
11/02/1999CA2053911C Recombinant antibody-toxin fusion protein
11/02/1999CA2002788C Adp glucose-pyrophosphorylase
11/02/1999CA1340810C Polypeptide derivatives of human granulocyte colony stimulating factor
10/1999
10/28/1999WO1999054738A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
10/28/1999WO1999054737A1 Immunodiagnostic method for granzymes
10/28/1999WO1999054733A1 Detection and diagnosis of conditions associated with lung injury
10/28/1999WO1999054504A1 Method of designing an agent that mimics a functional epitope
10/28/1999WO1999054493A2 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
10/28/1999WO1999054484A1 Modified immunoglobulin molecules and methods for use thereof
10/28/1999WO1999054480A1 Transgenic plants presenting a modified inulin producing profile
10/28/1999WO1999054469A1 B-cell growth factor related protein
10/28/1999WO1999054468A1 Soluble protein ztmpo-1
10/28/1999WO1999054467A1 Sh2 domain-containing peptides
10/28/1999WO1999054465A2 Gene encoding syntaxin interacting protein
10/28/1999WO1999054464A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
10/28/1999WO1999054463A2 Human k+ ion channel and therapeutic applications thereof
10/28/1999WO1999054461A2 Human nucleic acid sequences of endometrium tumour tissue
10/28/1999WO1999054460A2 Human nucleic acid sequences of normal bladder tissue
10/28/1999WO1999054457A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates
10/28/1999WO1999054448A2 Human nucleic acid sequences, increased expression thereof in uterus myoma tissue
10/28/1999WO1999054447A2 Human nucleic acid sequences of bladder tumour tissue
10/28/1999WO1999054446A2 Human nucleic acid sequences which are overexpressed in normal pancreas tissue
10/28/1999WO1999054440A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
10/28/1999WO1999054354A1 Sp22, a fertility-associated protein from sperm and a method for evaluating and affecting male fertility using it
10/28/1999WO1999054353A2 Human nucleic acid sequences of normal uterus tissue
10/28/1999WO1999054350A1 Novel omega conotoxin peptides
10/28/1999WO1999054349A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999WO1999054342A1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
10/28/1999WO1999053958A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
10/28/1999WO1999053954A1 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
10/28/1999WO1999053952A1 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum
10/28/1999WO1999053938A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof
10/28/1999WO1999053900A1 Drug delivery of proteins from polymeric blends
10/28/1999WO1999042839A3 Treating cancer
10/28/1999WO1999041404A3 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
10/28/1999WO1999037763A9 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
10/28/1999WO1999037299B1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
10/28/1999WO1999027080A3 Human protein kinase and kinase inhibitors
10/28/1999WO1998040099A9 Leptospira pathogens
10/28/1999DE19818620A1 New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents
10/28/1999DE19818619A1 New nucleic acid sequences expressed in bladder tumor tissue, and derived polypeptides, for treatment of bladder tumor and identification of therapeutic agents